| 1 |
Vezzani A. Epilepsy and inflammation in the brain: overview and pathophysiology[J]. Epilepsy Curr, 2014, 14(1 Suppl): 3-7.
|
| 2 |
Walker L, Sills GJ.Inflammation and epilepsy: the foundations for a new therapeutic approach in epilepsy？[J]. Epilepsy Curr, 2012, 12(1): 8-12.
|
| 3 |
Kim YS, Joh TH.Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson’s disease[J]. Exp Mol Med, 2006, 38(4): 333-347.
|
| 4 |
Walker DG, Whetzel AM, Lue LF.Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microglia[J]. Neuroscience, 2015, 302: 121-137.
|
| 5 |
Emsley HC, Appleton RE, Whitmore CL, et al. Variations in inflammation-related genes may be associated with childhood febrile seizure susceptibility[J]. Seizure, 2014, 23(6): 457-461.
|
| 6 |
Choy M, Dubé CM, Ehrengruber M, et al.Inflammatory processes, febrile seizures, and subsequent epileptogenesis[J]. Epilepsy Curr, 2014, 14(1 Suppl): 15-22.
|
| 7 |
Matsunaga N, Tsuchimori N, Matsumoto T, et al. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules[J]. Mol Pharmacol, 2011, 79(1): 34-41.
|
| 8 |
贾建平，陈生弟．神经病学[M]．北京：人民卫生出版社，2013：297.
|
| 9 |
Song P, Liu Y, Yu X, et al. Prevalence of epilepsy in China between 1990 and 2015: A systematic review and meta-analysis[J]. J Glob Health, 2017, 7(2): 20706.
|
| 10 |
Nau AL, Mwape KE, Wiefek J, et al.Cognitive impairment and quality of life of people with epilepsy and neurocysticercosis in Zambia[J]. Epilepsy Behav, 2017, S1525-5050(17): 30464-X.
|
| 11 |
Wilcox KS, Vezzani A. Does brain inflammation mediate pathological outcomes in epilepsy？[J]. Adv Exp Med Biol, 2014, 813: 169-183.
|
| 12 |
Devinsky O, Vezzani A, Najjar S, et al.Glia and epilepsy: excitability and inflammation[J]. Trends Neurosci, 2013, 36(3): 174-184.
|
| 13 |
Riazi K, Galic MA, Pittman QJ.Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability[J]. Epilepsy Res, 2010, 89(1): 34-42.
|
| 14 |
Rodgers KM, Hutchinson MR, Northcutt A, et al.The cortical innate immune response increases local neuronal excitability leading to seizures[J]. Brain, 2009, 132(Pt 9): 2478-2486.
|
| 15 |
Klein M, Obermaier B, Angele B, et al.Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4[J]. J Infect Dis, 2008, 198(7): 1028-1036.
|
| 16 |
Medzhitov R, Preston-Hurlburt P, Janeway C J. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J]. Nature, 1997, 388(6640): 394-397.
|
| 17 |
Wu Y, Li W, Zhou C, et al.Ketamine inhibits lipopolysaccharide-induced astrocytes activation by suppressing TLR4/NF-kB pathway[J]. Cell Physiol Biochem, 2012, 30(3): 609-617.
|
| 18 |
Cohen P. The TLR and IL-1 signalling network at a glance[J]. J Cell Sci, 2014, 127(Pt 11): 2383-2390.
|
| 19 |
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity[J]. Cell, 2006, 124(4): 783-801.
|
| 20 |
Rice TW, Wheeler AP, Bernard GR, et al.A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis[J]. Crit Care Med, 2010, 38(8): 1685-1694.
|
| 21 |
Rajamani U, Jialal I. Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy[J]. J Diabetes Res, 2014, 2014: 790902.
|